VENOSMIL

Indications

• Low blood volume
• Hypovolemic shock
• Burns
• Cardiopulmonary bypass

Dosage

Children: Initially 10-20 mL per kilogram. Adjust according to the patient's condition and response, using 3.5-4% solution. Use under specialist supervision to mitigate the risk of fluid overload.

Adults: Dose according to requirements, typically administered intravenously. Consult product literature for specific dosing guidance.

Mechanism of action

Gelatin acts as a plasma expander by increasing the oncotic pressure in the vascular compartment, which helps to retain fluid within the bloodstream and restore circulating blood volume. This mechanism aids in maintaining blood pressure and improving tissue perfusion.

Pharmacodynamics

Gelatin solutions increase blood volume and improve hemodynamic stability in patients experiencing hypovolemic conditions. By drawing water into the vascular space, they help to counteract the effects of low blood volume, such as hypotension and compromised organ perfusion.

Pharmacokinetics

Gelatin is administered intravenously, and its effects can be observed relatively quickly. The half-life and the metabolic clearance depend on the formulation and concentration of the solution. Gelatin is gradually metabolized by macrophages and eliminated by the renal system. Close monitoring of fluid balance is essential, particularly in patients with cardiac or renal impairment.

Contra-indications

• Severe liver disease
• History of circulatory disease
• Severe cardiac disease

Adverse effects

• Fever
• Flushing
• Nausea
• Urticaria
• Rare or very rare shock

Interactions

• Calcium salts

Precautions

• Monitor cardiovascular and respiratory function
• Correct dehydration when administering
• Administer slowly to avoid rapid rise in blood pressure and cardiac failure
• Increased capillary permeability

Pregnancy

Consult product literature for specific guidance regarding use in pregnancy.

Breast-feeding

Consult product literature for specific guidance regarding use in breastfeeding.

Storage

Store at controlled room temperature, protect from light. Refer to product-specific storage instructions.

Formulations

• 5% solution for infusion
• 20% solution for infusion
• Concentrated solution (15-25% protein)
• Isotonic solution (3.5-5% protein)

Dosage

Children: Refer to specific drug guidelines for dosing information.

Adults: Refer to specific drug guidelines for dosing information.

Mechanism of action

The body operates through various biological mechanisms that involve the interaction of hormones, neurotransmitters, and enzymes. These interactions regulate numerous physiological processes including homeostasis, immune response, and metabolic pathways.

Pharmacodynamics

Pharmacodynamics in the context of the body involves understanding how different substances affect bodily functions. This can include the action of drugs, nutrients, and other chemical agents, which can modify physiological responses through receptor binding, enzyme activity modulation, or ion channel regulation.

Pharmacokinetics

Pharmacokinetics refers to how substances are absorbed, distributed, metabolized, and excreted within the body. Factors such as blood flow, tissue permeability, and enzymatic activity play crucial roles in determining how long a drug remains active in the body, its efficacy, and potential for toxicity.

Pregnancy

Consult healthcare provider before use, as safety during pregnancy may vary based on specific conditions.

Breast-feeding

Consult healthcare provider before use, as safety during breastfeeding may vary based on specific conditions.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Dosage

Children: Refer to the specific drug formulation and BNF for Children for appropriate dosing information.

Adults: Refer to the specific drug formulation and BNF for appropriate dosing information.

Mechanism of action

The mechanism of action of a drug depends on its specific active ingredients. Generally, drugs interact with biological systems through various pathways, such as binding to receptors, inhibiting enzymes, or altering cellular processes. This interaction leads to a therapeutic effect, which can vary widely depending on the drug's composition.

Pharmacodynamics

Pharmacodynamics refers to the effects of a drug on the body and the mechanisms through which these effects occur. The pharmacodynamic profile of a drug is influenced by its composition, including the potency of active ingredients, the affinity to specific receptors, and the ability to cross biological membranes. The overall therapeutic effect is determined by how these components interact with the body's biological systems.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion of a drug. The composition of a drug affects its pharmacokinetics; for instance, solubility, stability, and formulation type can influence absorption rates. Different formulations may have varying bioavailability, which is crucial for achieving therapeutic effects. Metabolism can be influenced by the presence of excipients or other components that affect enzymatic activity.

Pregnancy

Consult healthcare provider. The safety of composition during pregnancy has not been established.

Breast-feeding

Consult healthcare provider. It is unknown if composition is excreted in human milk.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Indications

• Chronic venous insufficiency
• Hemorrhoids
• Varicose veins
• Lymphedema

Dosage

Children: Paediatric dosing information for hidrosmin is not readily available; therefore, it is recommended to consult the BNF for Children or a healthcare professional for appropriate dosing in children.

Adults: For adults, the typical dosage of hidrosmin is 500 mg to 1000 mg taken orally, usually divided into two or three doses per day. It is advisable to refer to specific guidelines or the BNF for further details regarding dosing adjustments based on individual patient needs.

Mechanism of action

Hidrosmin exerts a venotonic effect by enhancing venous tone, which is mediated through a combination of increased venous return and reduced venous distensibility. This is thought to be due to its action on the vascular smooth muscle, promoting contraction and thereby improving venous drainage. Additionally, it may decrease capillary permeability and inhibit inflammatory mediators, contributing to its effectiveness in venous disorders.

Pharmacodynamics

Pharmacodynamically, hidrosmin improves microcirculation and reduces venous stasis, which can alleviate symptoms associated with venous insufficiency such as pain, swelling, and heaviness in the legs. Its anti-inflammatory properties may also play a role in reducing discomfort associated with hemorrhoids and other inflammatory vascular conditions.

Pharmacokinetics

Hidrosmin is well absorbed after oral administration, with peak plasma concentrations typically occurring within 1-2 hours. It undergoes extensive hepatic metabolism, resulting in several metabolites that may also contribute to its therapeutic effects. The elimination half-life is approximately 4-6 hours, and it is primarily excreted through the urine.

Pregnancy

There is limited data on the use of hidrosmin during pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

There is insufficient information on the excretion of hidrosmin in human milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.